Generative AI Transforms Enterprise Virtual Assistant Capabilities

Information TechnologyGenerative AI Transforms Enterprise Virtual Assistant Capabilities

Unlocking Enterprise Value to Help Fuel Business Growth

RELEASE DATE
05-Nov-2024
REGION
Global
Deliverable Type
Market Research
Research Code: PFP4-01-00-00-00
SKU: IT_2024_1100
AvailableYesPDF Download
$2,450.00
In stock
SKU
IT_2024_1100

Generative AI Transforms Enterprise Virtual Assistant Capabilities
Published on: 05-Nov-2024 | SKU: IT_2024_1100

Need more details?
$2,450.00
DownloadLink
Need more details?

Digital Transformation alters the way organizations function as well as all aspects of business. Organizations are investing in technologies that render them more data-centric and drive greater competitiveness in the digital economy. In that context, the emergence of virtual assistants and copilots marks a significant leap in the AI space. Virtual assistants have the potential to transform how organizations operate and engage with customers, employees, and partners. These agents, powered by natural language processing capabilities, can handle a broad spectrum of activities and assist users in automating routine tasks, thereby driving greater efficiencies.

Generative AI is further transforming the capabilities of virtual assistants by leveraging large language models to make human-machine interactions more intuitive and support real-time interactions in multiple languages and data formats, including voice, text, and image.

With the continuous evolution of virtual assistants, the technology will be able to create greater value and support strategic activities, becoming an indispensable tool. Virtual assistants will integrate seamlessly with enterprise technologies, supporting a broad spectrum of stakeholders. This Frost & Sullivan analysis highlights the main trends around virtual assistants and their business value.

Author: Bernardin Arnason

Driving Better Customer Experience, Employee Experience, and Operational Efficiencies is a Strategic Business Priority

Virtual Assistants are Key Tools for Enabling Enterprise-wide CX, EX, and Operational Efficiency

Generative AI is Transforming VA Capabilities

VA Capabilities are Evolving Rapidly Thanks to AI

GenAI VAs Enable the Digital Enterprise, Enhancing Value and Business Growth

Assessing the Impact of VAs

VAs are Now a Key Driver to AI-powered Communication Capabilities

The Maturing Technology Stack is Accelerating the Business Value, while Reducing Adoption Barriers for VAs

The Way Forward: Besides Data Security, Responsible AI Best Practices will be Fundamental in Ensuring Enterprise-wide Deployments

The Way Forward: Increasing Integration of VAs into Enterprise Applications Requires Effective Data Security Strategies

The Way Forward: Enterprise AI Implementation Strategy

The Way Forward: Enterprise AI Implementation Factors

Key VA Platforms

High Level Microsoft Office 365 Copilot: Architecture

Microsoft Office 365 Copilot: Key Features

Benefits and Impacts of Growth Opportunities

Action Items & Next Steps

Legal Disclaimer

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification. This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts. Author: Bernardin Arnason
More Information
Deliverable Type Market Research
Author Bernardin Arnason
Industries Information Technology
No Index No
Is Prebook No
Keyword 1 Generative Ai Virtual Assistants
Keyword 2 Enterprise Ai Tools
Keyword 3 Ai Transformation
Podcast No
WIP Number PFP4-01-00-00-00